433 related articles for article (PubMed ID: 30367820)
1. 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs.
Nunes AS; Barros AS; Costa EC; Moreira AF; Correia IJ
Biotechnol Bioeng; 2019 Jan; 116(1):206-226. PubMed ID: 30367820
[TBL] [Abstract][Full Text] [Related]
2. Establishment of 2D Cell Cultures Derived From 3D MCF-7 Spheroids Displaying a Doxorubicin Resistant Profile.
Nunes AS; Costa EC; Barros AS; de Melo-Diogo D; Correia IJ
Biotechnol J; 2019 Apr; 14(4):e1800268. PubMed ID: 30242980
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Size-Based Analysis of Tumor Spheroids and Responses to Therapeutics.
Thakuri PS; Gupta M; Plaster M; Tavana H
Assay Drug Dev Technol; 2019 Apr; 17(3):140-149. PubMed ID: 30958703
[TBL] [Abstract][Full Text] [Related]
4. Application of Three-dimensional (3D) Tumor Cell Culture Systems and Mechanism of Drug Resistance.
Shehzad A; Ravinayagam V; AlRumaih H; Aljafary M; Almohazey D; Almofty S; Al-Rashid NA; Al-Suhaimi EA
Curr Pharm Des; 2019; 25(34):3599-3607. PubMed ID: 31612821
[TBL] [Abstract][Full Text] [Related]
5. 3D tumor spheroids: an overview on the tools and techniques used for their analysis.
Costa EC; Moreira AF; de Melo-Diogo D; Gaspar VM; Carvalho MP; Correia IJ
Biotechnol Adv; 2016 Dec; 34(8):1427-1441. PubMed ID: 27845258
[TBL] [Abstract][Full Text] [Related]
6. Three dimensional cultivation increases chemo- and radioresistance of colorectal cancer cell lines.
Koch J; Mönch D; Maaß A; Gromoll C; Hehr T; Leibold T; Schlitt HJ; Dahlke MH; Renner P
PLoS One; 2021; 16(1):e0244513. PubMed ID: 33395433
[TBL] [Abstract][Full Text] [Related]
7. Experimental anti-tumor therapy in 3-D: spheroids--old hat or new challenge?
Friedrich J; Ebner R; Kunz-Schughart LA
Int J Radiat Biol; 2007; 83(11-12):849-71. PubMed ID: 18058370
[TBL] [Abstract][Full Text] [Related]
8. Formation of multicellular tumor spheroids induced by cyclic RGD-peptides and use for anticancer drug testing in vitro.
Akasov R; Zaytseva-Zotova D; Burov S; Leko M; Dontenwill M; Chiper M; Vandamme T; Markvicheva E
Int J Pharm; 2016 Jun; 506(1-2):148-57. PubMed ID: 27107900
[TBL] [Abstract][Full Text] [Related]
9. Engineered Breast Cancer Cell Spheroids Reproduce Biologic Properties of Solid Tumors.
Ham SL; Joshi R; Luker GD; Tavana H
Adv Healthc Mater; 2016 Nov; 5(21):2788-2798. PubMed ID: 27603912
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the physical properties of tumor-derived spheroids reveals critical insights for pre-clinical studies.
Guillaume L; Rigal L; Fehrenbach J; Severac C; Ducommun B; Lobjois V
Sci Rep; 2019 Apr; 9(1):6597. PubMed ID: 31036886
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic and molecular differences of anticancer agents on 2D and 3D cell culture.
Alwahsh M; Al-Doridee A; Jasim S; Awwad O; Hergenröder R; Hamadneh L
Mol Biol Rep; 2024 Jun; 51(1):721. PubMed ID: 38829450
[TBL] [Abstract][Full Text] [Related]
12. Human neuroendocrine tumor cell lines as a three-dimensional model for the study of human neuroendocrine tumor therapy.
Wong C; Vosburgh E; Levine AJ; Cong L; Xu EY
J Vis Exp; 2012 Aug; (66):e4218. PubMed ID: 22929519
[TBL] [Abstract][Full Text] [Related]
13. Applicability of tumor spheroids for
Hamilton G; Rath B
Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):15-23. PubMed ID: 30484335
[No Abstract] [Full Text] [Related]
14. LA-ICP-MS imaging in multicellular tumor spheroids - a novel tool in the preclinical development of metal-based anticancer drugs.
Theiner S; Schreiber-Brynzak E; Jakupec MA; Galanski M; Koellensperger G; Keppler BK
Metallomics; 2016 Apr; 8(4):398-402. PubMed ID: 26806253
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer.
Imamura Y; Mukohara T; Shimono Y; Funakoshi Y; Chayahara N; Toyoda M; Kiyota N; Takao S; Kono S; Nakatsura T; Minami H
Oncol Rep; 2015 Apr; 33(4):1837-43. PubMed ID: 25634491
[TBL] [Abstract][Full Text] [Related]
16. Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids.
Senkowski W; Jarvius M; Rubin J; Lengqvist J; Gustafsson MG; Nygren P; Kultima K; Larsson R; Fryknäs M
Cell Chem Biol; 2016 Nov; 23(11):1428-1438. PubMed ID: 27984028
[TBL] [Abstract][Full Text] [Related]
17. Licofelone Enhances the Efficacy of Paclitaxel in Ovarian Cancer by Reversing Drug Resistance and Tumor Stem-like Properties.
Hirst J; Pathak HB; Hyter S; Pessetto ZY; Ly T; Graw S; Koestler DC; Krieg AJ; Roby KF; Godwin AK
Cancer Res; 2018 Aug; 78(15):4370-4385. PubMed ID: 29891506
[TBL] [Abstract][Full Text] [Related]
18. Reversal of intrinsic and acquired forms of drug resistance by hyaluronidase treatment of solid tumors.
St Croix B; Man S; Kerbel RS
Cancer Lett; 1998 Sep; 131(1):35-44. PubMed ID: 9839618
[TBL] [Abstract][Full Text] [Related]
19. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
Frankel A; Man S; Elliott P; Adams J; Kerbel RS
Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Testing of Anticancer Nanotherapeutics Using Tumor Spheroids.
Ganpule A; Gui Z; Almuteri MA; D'Souza GGM
Methods Mol Biol; 2019; 2000():387-393. PubMed ID: 31148027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
